NEW YORK (GenomeWeb) – WaferGen Biosystems is preparing to sell an undisclosed amount of Class A and Class B units to raise up to $34.5 million in a public offering, according to a document filed with the US Securities and Exchange Commission.

In a Form S-1 filed Aug. 14, the firm said it will offer an undisclosed number of Class A units, consisting of shares of the firm's common stock and warrants to purchase shares of common stock. Each warrant will allow the holder to purchase one share of WaferGen's stock at an exercise price still to be determined.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.